vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and SHORE BANCSHARES INC (SHBI). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $59.1M, roughly 1.4× SHORE BANCSHARES INC). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 11.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 11.3%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Shore Bancshares Inc. is a U.S. regional bank holding company headquartered in Maryland. It offers a full range of retail and commercial banking services, including deposit products, personal and commercial loans, and wealth management solutions, primarily serving local individual customers, small businesses and mid-sized enterprises in its operating regions.

PRCT vs SHBI — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.4× larger
PRCT
$83.1M
$59.1M
SHBI
Growing faster (revenue YoY)
PRCT
PRCT
+8.4% gap
PRCT
20.2%
11.8%
SHBI
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
11.3%
SHBI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
SHBI
SHBI
Revenue
$83.1M
$59.1M
Net Profit
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
35.2%
Net Margin
-38.1%
Revenue YoY
20.2%
11.8%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.56
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SHBI
SHBI
Q1 26
$83.1M
Q4 25
$76.4M
$59.1M
Q3 25
$83.3M
$56.4M
Q2 25
$79.2M
$56.6M
Q1 25
$69.2M
$53.0M
Q4 24
$68.2M
$52.9M
Q3 24
$58.4M
$50.5M
Q2 24
$53.4M
$50.6M
Net Profit
PRCT
PRCT
SHBI
SHBI
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-21.4M
$14.3M
Q2 25
$-19.6M
$15.5M
Q1 25
$-24.7M
$13.8M
Q4 24
$-18.9M
Q3 24
$-21.0M
$11.2M
Q2 24
$-25.6M
$11.2M
Gross Margin
PRCT
PRCT
SHBI
SHBI
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
SHBI
SHBI
Q1 26
-4.1%
Q4 25
-40.6%
35.2%
Q3 25
-27.8%
33.7%
Q2 25
-28.0%
36.5%
Q1 25
-39.7%
34.4%
Q4 24
-28.9%
34.3%
Q3 24
-38.4%
29.6%
Q2 24
-50.3%
29.7%
Net Margin
PRCT
PRCT
SHBI
SHBI
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-25.7%
25.5%
Q2 25
-24.7%
27.4%
Q1 25
-35.8%
26.0%
Q4 24
-27.6%
Q3 24
-35.9%
22.1%
Q2 24
-48.0%
22.2%
EPS (diluted)
PRCT
PRCT
SHBI
SHBI
Q1 26
$-0.56
Q4 25
$-0.54
$0.48
Q3 25
$-0.38
$0.43
Q2 25
$-0.35
$0.46
Q1 25
$-0.45
$0.41
Q4 24
$-0.34
$0.39
Q3 24
$-0.40
$0.34
Q2 24
$-0.50
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SHBI
SHBI
Cash + ST InvestmentsLiquidity on hand
$245.6M
$355.6M
Total DebtLower is stronger
$51.7M
$89.1M
Stockholders' EquityBook value
$347.7M
$589.9M
Total Assets
$487.1M
$6.3B
Debt / EquityLower = less leverage
0.15×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SHBI
SHBI
Q1 26
$245.6M
Q4 25
$286.5M
$355.6M
Q3 25
$294.3M
$416.5M
Q2 25
$302.7M
$185.0M
Q1 25
$316.2M
$389.0M
Q4 24
$333.7M
$459.9M
Q3 24
$196.8M
$183.6M
Q2 24
$214.1M
$138.9M
Total Debt
PRCT
PRCT
SHBI
SHBI
Q1 26
$51.7M
Q4 25
$51.6M
$89.1M
Q3 25
$51.6M
$74.5M
Q2 25
$51.5M
$74.2M
Q1 25
$51.5M
$74.0M
Q4 24
$51.5M
$73.7M
Q3 24
$51.4M
$123.5M
Q2 24
$51.4M
$122.8M
Stockholders' Equity
PRCT
PRCT
SHBI
SHBI
Q1 26
$347.7M
Q4 25
$365.9M
$589.9M
Q3 25
$380.3M
$577.2M
Q2 25
$385.8M
$565.2M
Q1 25
$389.2M
$552.5M
Q4 24
$402.2M
$541.1M
Q3 24
$241.2M
$533.3M
Q2 24
$251.8M
$522.8M
Total Assets
PRCT
PRCT
SHBI
SHBI
Q1 26
$487.1M
Q4 25
$508.1M
$6.3B
Q3 25
$511.5M
$6.3B
Q2 25
$513.1M
$6.0B
Q1 25
$519.4M
$6.2B
Q4 24
$534.0M
$6.2B
Q3 24
$374.1M
$5.9B
Q2 24
$374.4M
$5.9B
Debt / Equity
PRCT
PRCT
SHBI
SHBI
Q1 26
0.15×
Q4 25
0.14×
0.15×
Q3 25
0.14×
0.13×
Q2 25
0.13×
0.13×
Q1 25
0.13×
0.13×
Q4 24
0.13×
0.14×
Q3 24
0.21×
0.23×
Q2 24
0.20×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SHBI
SHBI
Operating Cash FlowLast quarter
$62.4M
Free Cash FlowOCF − Capex
$59.2M
FCF MarginFCF / Revenue
100.2%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$110.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SHBI
SHBI
Q1 26
Q4 25
$-10.3M
$62.4M
Q3 25
$-6.6M
$42.5M
Q2 25
$-15.0M
$-8.3M
Q1 25
$-17.0M
$19.8M
Q4 24
$-32.4M
$46.9M
Q3 24
$-18.8M
$9.1M
Q2 24
$-15.7M
$3.0M
Free Cash Flow
PRCT
PRCT
SHBI
SHBI
Q1 26
Q4 25
$-12.2M
$59.2M
Q3 25
$-9.5M
$41.9M
Q2 25
$-17.8M
$-9.2M
Q1 25
$-18.8M
$18.8M
Q4 24
$-33.6M
$41.7M
Q3 24
$-19.0M
$8.4M
Q2 24
$-16.8M
$1.4M
FCF Margin
PRCT
PRCT
SHBI
SHBI
Q1 26
Q4 25
-15.9%
100.2%
Q3 25
-11.4%
74.3%
Q2 25
-22.5%
-16.3%
Q1 25
-27.2%
35.4%
Q4 24
-49.2%
78.8%
Q3 24
-32.6%
16.7%
Q2 24
-31.4%
2.9%
Capex Intensity
PRCT
PRCT
SHBI
SHBI
Q1 26
Q4 25
2.4%
5.4%
Q3 25
3.4%
1.0%
Q2 25
3.5%
1.6%
Q1 25
2.7%
1.9%
Q4 24
1.7%
9.9%
Q3 24
0.4%
1.2%
Q2 24
2.0%
3.1%
Cash Conversion
PRCT
PRCT
SHBI
SHBI
Q1 26
Q4 25
Q3 25
2.96×
Q2 25
-0.54×
Q1 25
1.44×
Q4 24
Q3 24
0.81×
Q2 24
0.27×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SHBI
SHBI

Segment breakdown not available.

Related Comparisons